Brief: Alembic Pharma Gets USFDA Final Approval For Paroxetine Extended-Release Tablets 12.5 Mg
27/03/2026 10:35
March 27 (Reuters) - Alembic Pharmaceuticals Ltd ALEM.NS: RECEIVES USFDA FINAL APPROVAL FOR PAROXETINE EXTENDED-RELEASE TABLETS 12.5 MG Source text: ID:nNSE7Pbgb2 Further company coverage: ALEM.NS ((Reutersbriefs@thomsonreuters.com;))
Recent news on Alembic Pharmaceuticals
See all newsIndia's Alembic Pharma rises after US FDA approves herpesvirus drug
Brief: Alembic Pharmaceuticals Receives USFDA Final Approval For Valganciclovir Oral Solution 50 Mg/Ml
Brief: Alembic Pharmaceuticals Completes USFDA Bioequivalence Inspection At Vadodara With No Observations
India's Alembic Pharma gains as brokerages optimistic after quarterly profit rise
India's Alembic Pharma posts quarterly profit rise on strong generics demand